SYTL4
Basic information
Region (hg38): X:100671783-100732123
Links
Transcripts
Transcript IDs starting with ENST are treated as Ensembl, all others as RefSeq. Showing 4 of 47.
| Transcript ID | Protein ID | Coding exons | MANE Select | MANE Plus Clinical |
|---|---|---|---|---|
NM_001370165.1 | NP_001357094.1 | 16 | yes | - |
ENST00000372989.6 | ENSP00000362080.1 | 16 | yes | - |
NM_080737.3 | NP_542775.2 | 16 | - | - |
NM_001129896.3 | NP_001123368.1 | 16 | - | - |
Phenotypes
GenCC
Source:
- retinal disorder (Limited), mode of inheritance: XL
ClinVar
This is a list of variants' phenotypes submitted to
- not_specified (66 variants)
- not_provided (5 variants)
- Congenital_portosystemic_shunt (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the SYTL4 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001370165.1. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 14 | 1 | 15 | |||
| missense | 102 | 3 | 105 | |||
| nonsense | 4 | 4 | ||||
| start loss | 0 | |||||
| frameshift | 0 | |||||
| splice donor/acceptor (+/-2bp) | 17 | 17 | ||||
| Total | 0 | 0 | 137 | 4 | 0 |
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| SYTL4 | protein_coding | protein_coding | ENST00000455616 | 16 | 57623 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 125701 | 10 | 26 | 125737 | 0.000143 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 0.812 | 222 | 259 | 0.858 | 0.0000204 | 4430 |
| Missense in Polyphen | 70 | 94.865 | 0.73789 | 1587 | ||
| Synonymous | 2.15 | 65 | 91.1 | 0.713 | 0.00000661 | 1255 |
| Loss of Function | 3.21 | 8 | 25.5 | 0.314 | 0.00000191 | 444 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000528 | 0.000528 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.000223 | 0.000149 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000597 | 0.0000327 |
| Other | 0.000955 | 0.000652 |
dbNSFP
Source:
- Function
- FUNCTION: Modulates exocytosis of dense-core granules and secretion of hormones in the pancreas and the pituitary. Interacts with vesicles containing negatively charged phospholipids in a Ca(2+)-independent manner (By similarity). {ECO:0000250}.;
- Pathway
- Deregulation of Rab and Rab Effector Genes in Bladder Cancer;Platelet degranulation ;Response to elevated platelet cytosolic Ca2+;Platelet activation, signaling and aggregation;Hemostasis
(Consensus)
Recessive Scores
- pRec
- 0.129
Intolerance Scores
- loftool
- 0.729
- rvis_EVS
- 0.26
- rvis_percentile_EVS
- 70.44
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.524
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- platelet degranulation;intracellular protein transport;positive regulation of exocytosis;negative regulation of insulin secretion;positive regulation of protein secretion;multivesicular body sorting pathway
- Cellular component
- nucleoplasm;endosome;microtubule organizing center;cytosol;plasma membrane;extrinsic component of membrane;transport vesicle membrane;platelet alpha granule membrane;exocytic vesicle
- Molecular function
- protein binding;phospholipid binding;Rab GTPase binding;neurexin family protein binding;metal ion binding